NCT00765687

Screening Non Small Cell Lung Cancer With Bone Metastasis and Efficacy and Safety Research of Receiving Bisphosphonates

A Multi-center Observational Clinical Study of Screening of Non-small-cell Lung Cancer With Bone Metastasis and Efficacy and Safety of Those Receiving Bisphosphonates

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 432 (actual)
• Sponsor: Sun Yat-sen University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

A multicenter Prospective Study to assess the screening methods, parameter of NTX and the efficacy and safety of zoledronic acid treatment in addition to anti-tumor therapy in patients of non-small cell cancer with bone metastasis in china.

Conditions

• Non-small Cell Lung Cancer
• Bone Metastases

Interventions

Type	Name	Description
DRUG	bisphosphates	any bisphosphate, repeated every 4 weeks for up to 24 months. Co-administration with Zometa: Calcium 500 mg + vitamin D 400-500 IU daily

Timeline

• Start date: 2008-08-01
• Primary completion: 2012-05-01
• Completion: 2012-05-01
• First posted: 2008-10-03
• Last updated: 2013-12-10

Locations

1 site across 1 country: China